Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TiCAB – Ticagrelor in CABG
DRKS00004917Phase 3Terminated
- Sponsor
- Deutsches Herzzentrum München
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of ticagrelor in coronary arteriosclerosis and atherosclerosis (2 arms), sponsored by Deutsches Herzzentrum München. Started Apr 2013; status: terminated.
02
Drugs
ticagrelor
03
Conditions
coronary arteriosclerosisatherosclerosis
Beyond the preview
Go deeper on DRKS00004917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004917.